INFLIXIMAB

Clinical trials for INFLIXIMAB explained in plain language.

Never miss a new study

Get alerted when new INFLIXIMAB trials appear

Sign up with your email to follow new studies for INFLIXIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Could a 30-Minute infusion be as safe as an hour for kids with IBD?

Symptom relief Ongoing

This study compares giving the drug infliximab over 30 minutes versus the standard 60 minutes in children with inflammatory bowel disease (IBD). The goal is to see if the shorter infusion causes just as few allergic reactions and improves patient and nurse satisfaction. Sixty chi…

Matched conditions: INFLIXIMAB

Phase: NA • Sponsor: University Hospital, Akershus • Aim: Symptom relief

Last updated Jun 27, 2026 12:24 UTC

INFLIXIMAB

Get alerted when new INFLIXIMAB trials appear

Could a 30-Minute infusion be as safe as an hour for kids with IBD?